UNRESECTABLE LIPOSARCOMA
Clinical trials for UNRESECTABLE LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE LIPOSARCOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: experimental drug targets rare sarcomas
Disease control Recruiting nowThis early-stage study is testing whether a new drug called BTX-A51 is safe for people with advanced liposarcoma, a rare type of cancer. Researchers will give the drug to about 24 patients whose cancer has returned or spread, and monitor them closely for side effects. The study w…
Matched conditions: UNRESECTABLE LIPOSARCOMA
Phase: PHASE1 • Sponsor: Michael Wagner, MD • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug duo aims to halt aggressive fat tissue cancer
Disease control Recruiting nowThis study is testing whether combining two drugs, mirdametinib and palbociclib, is safe and effective for people with advanced liposarcoma that has spread, returned, or cannot be surgically removed. Researchers will first find the safest dose of mirdametinib to give with a fixed…
Matched conditions: UNRESECTABLE LIPOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC